Home/Filings/4/0001140361-21-037042
4//SEC Filing

Vendola Keith A. 4

Accession 0001140361-21-037042

CIK 0001865494other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 6:37 PM ET

Size

5.2 KB

Accession

0001140361-21-037042

Insider Transaction Report

Form 4
Period: 2021-11-04
Vendola Keith A.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-11-04+69,46969,469 total
    Exercise: $14.00Exp: 2031-11-04Common Stock (69,469 underlying)
Footnotes (1)
  • [F1]These options vest 25% on the one-year anniversary of the vesting commencement date of November 4, 2021, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.

Issuer

IO Biotech, Inc.

CIK 0001865494

Entity typeother

Related Parties

1
  • filerCIK 0001740994

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 6:37 PM ET
Size
5.2 KB